Transcription factor Zbtb38 downregulates the expression of anti-inflammatory IL1r2 in mouse model of rheumatoid arthritis.
Transcription factor Zbtb38 downregulates the expression of anti-inflammatory IL1r2 in mouse model of rheumatoid arthritis.
复制标题
DOI:
10.1016/j.bbagrm.2018.09.007
复制
发表时间:
2018-11
期刊:
影响因子:
--
通讯作者:
T. Ocskó;D. Tóth;Gyula Hoffmann;Vilmos Tubak;T. Glant;T. Rauch
中科院分区:
文献类型:
--
作者:
T. Ocskó;D. Tóth;Gyula Hoffmann;Vilmos Tubak;T. Glant;T. Rauch
DNA methylation is a decisive regulator of gene expression. Differentially methylated promoters were described in rheumatoid arthritis (RA), but we do not know how these epimutations can trigger a proinflammatory cytokine milieu. B cell-focused DNA methylome studies identified a group of genes that had undergone disease-associated changes in a murine model of RA. An arthritis-specific epimutation (hypomethylation) was detected in the promoter region of theZbtb38gene, which encodes a transcriptional repressor. Gene expression studies revealed that hypomethylation of theZbtb38promoter was accompanied by disease-specific repressor expression, and two anti-inflammatory factors interleukin 1 receptor 2 gene (IL1r2) and interleukin-1 receptor antagonist (IL1rn) were among the downregulated genes. We hypothesized that Zbtb38 repressor could induce downregulated expression of these anti-inflammatory genes and that this could significantly contribute to arthritis pathogenesis. Our studies demonstrate that Zbtb38 forms a molecular bridge between an arthritis-associated epimutation (DNA hypomethylation inZbtb38promoter) and transcriptional silencing of theIL1r2gene in B cells. In this way, disease-associated DNA hypomethylation can support autoimmune arthritis by interfering with an anti-inflammatory pathway.